EA200301324A1 - Вакцина mycoplasma bovis и способы сокращения пневмонии у животных - Google Patents

Вакцина mycoplasma bovis и способы сокращения пневмонии у животных

Info

Publication number
EA200301324A1
EA200301324A1 EA200301324A EA200301324A EA200301324A1 EA 200301324 A1 EA200301324 A1 EA 200301324A1 EA 200301324 A EA200301324 A EA 200301324A EA 200301324 A EA200301324 A EA 200301324A EA 200301324 A1 EA200301324 A1 EA 200301324A1
Authority
EA
Eurasian Patent Office
Prior art keywords
mycoplasma bovis
vaccine
methods
vaccines
animals
Prior art date
Application number
EA200301324A
Other languages
English (en)
Russian (ru)
Inventor
Робин Ли Кич
Дейвид Росс Магавин
Роберт Джон Янси
Original Assignee
Пфайзер Продактс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Продактс Инк. filed Critical Пфайзер Продактс Инк.
Publication of EA200301324A1 publication Critical patent/EA200301324A1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0241Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36Adaptation or attenuation of cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EA200301324A 2001-07-02 2002-06-27 Вакцина mycoplasma bovis и способы сокращения пневмонии у животных EA200301324A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30263801P 2001-07-02 2001-07-02
PCT/IB2002/002514 WO2003004052A1 (en) 2001-07-02 2002-06-27 Mycoplasma bovis vaccine and methods of reducing pneumonia in animals

Publications (1)

Publication Number Publication Date
EA200301324A1 true EA200301324A1 (ru) 2004-12-30

Family

ID=23168600

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200301324A EA200301324A1 (ru) 2001-07-02 2002-06-27 Вакцина mycoplasma bovis и способы сокращения пневмонии у животных

Country Status (31)

Country Link
US (1) US20030147914A1 (enExample)
EP (1) EP1401488A1 (enExample)
JP (1) JP2004536106A (enExample)
KR (1) KR20040030783A (enExample)
CN (1) CN1522152A (enExample)
AP (1) AP2002002568A0 (enExample)
AR (1) AR036125A1 (enExample)
BG (1) BG108496A (enExample)
BR (1) BR0210798A (enExample)
CA (1) CA2452580A1 (enExample)
CZ (1) CZ20033465A3 (enExample)
EA (1) EA200301324A1 (enExample)
GT (1) GT200200139A (enExample)
HN (1) HN2002000162A (enExample)
HR (1) HRP20031078A2 (enExample)
HU (1) HUP0501188A2 (enExample)
IL (1) IL159516A0 (enExample)
IS (1) IS7078A (enExample)
MA (1) MA27048A1 (enExample)
MX (1) MXPA03011815A (enExample)
NO (1) NO20035767L (enExample)
OA (1) OA12640A (enExample)
PA (1) PA8549801A1 (enExample)
PE (1) PE20030239A1 (enExample)
PL (1) PL373891A1 (enExample)
SK (1) SK15802003A3 (enExample)
TN (1) TNSN03154A1 (enExample)
UY (1) UY27365A1 (enExample)
WO (1) WO2003004052A1 (enExample)
YU (1) YU102103A (enExample)
ZA (1) ZA200309747B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
US7279166B2 (en) 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
US7572455B2 (en) * 2004-05-19 2009-08-11 Boehringer Ingelheim Vetmedica Gmbh Vaccine comprising an attenuated pestivirus
US20090068223A1 (en) * 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
WO2008030619A2 (en) * 2006-09-07 2008-03-13 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
MX2009001849A (es) 2006-09-11 2009-03-02 Pfizer Prod Inc Bacterinas tratadas con calor, y vacunas de emulsion preparadas a partir de estas bacterinas tratadas con calor.
CL2008003202A1 (es) * 2007-10-29 2009-11-27 Boehringer Ingelheim Vetmedica Inc Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
UY31930A (es) * 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
NZ589981A (en) * 2008-07-03 2012-11-30 Univ Iowa State Res Found Inc Cattle vaccines comprising a disrupted M. bovis bacterium
AU2009309041B2 (en) * 2008-10-31 2016-02-04 Boehringer Ingelheim Animal Health USA Inc. Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
US8846054B2 (en) * 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
KR20170077255A (ko) 2009-06-04 2017-07-05 고쿠리츠칸센쇼켄쿠죠 마이코플라즈마 감염증용 백신
CN102220263B (zh) * 2011-05-06 2012-10-03 华中农业大学 一种牛支原体致弱菌株及其应用
UA121193C2 (uk) 2012-12-28 2020-04-27 Бьорінгер Інгельхайм Ветмедіка Гмбх Спосіб одержання імуногенної композиції проти мікоплазми
CN104857509A (zh) * 2015-06-02 2015-08-26 福清市默克兽医院 牛支原体肺炎组织灭活疫苗的制备方法、配方及使用方法
CN108135989B (zh) 2015-08-14 2022-08-09 硕腾服务有限责任公司 牛支原体组合物
CN105441368B (zh) * 2016-01-19 2019-01-01 福清市默克兽医院 一株牛支原体及其应用
CN106929452B (zh) * 2017-04-11 2020-06-12 河南省农业科学院畜牧兽医研究所 一株牛支原体及其应用
CN109022314B (zh) * 2018-08-06 2021-08-13 北京华夏兴洋生物科技有限公司 一株牛支原体及其在疫苗研制中的应用
CN110338138B (zh) * 2019-06-19 2021-04-06 山东省农业科学院奶牛研究中心 一种牛支原体感染豚鼠的动物模型构建方法及其应用
CN112301041B (zh) * 2020-10-09 2022-05-24 华中农业大学 牛支原体p21蛋白及其应用
CN113546162B (zh) * 2021-05-31 2023-07-18 江苏省农业科学院 一种支原体疫苗及其制备方法
CN113604492B (zh) * 2021-09-10 2023-07-07 苏州世诺生物技术有限公司 融合基因、融合蛋白及制备方法和牛支原体亚单位疫苗

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
CA2390613A1 (en) * 1999-11-08 2001-05-17 Biomune Vaccines for mycoplasma bovis and methods of use
DE29921392U1 (de) * 1999-12-06 2000-03-16 Dr. Felgenträger & Co. Öko-Chem. und Pharma GmbH, 06862 Rodleben Mykoplasma-bovis-Kombinations-Vakzine für Rinder
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin

Also Published As

Publication number Publication date
TNSN03154A1 (fr) 2005-12-23
HN2002000162A (es) 2002-09-17
HRP20031078A2 (en) 2005-08-31
MXPA03011815A (es) 2004-04-02
SK15802003A3 (sk) 2005-01-03
PE20030239A1 (es) 2003-03-21
KR20040030783A (ko) 2004-04-09
WO2003004052A1 (en) 2003-01-16
BG108496A (en) 2005-02-28
IL159516A0 (en) 2004-06-01
JP2004536106A (ja) 2004-12-02
AR036125A1 (es) 2004-08-11
EP1401488A1 (en) 2004-03-31
HUP0501188A2 (en) 2006-05-29
NO20035767L (no) 2004-01-30
IS7078A (is) 2003-12-15
CA2452580A1 (en) 2003-01-16
BR0210798A (pt) 2006-05-23
US20030147914A1 (en) 2003-08-07
PA8549801A1 (es) 2003-09-17
MA27048A1 (fr) 2004-12-20
UY27365A1 (es) 2003-04-30
GT200200139A (es) 2003-02-13
PL373891A1 (en) 2005-09-19
ZA200309747B (en) 2005-05-27
CN1522152A (zh) 2004-08-18
YU102103A (sh) 2006-05-25
OA12640A (en) 2006-06-15
CZ20033465A3 (cs) 2004-12-15
AP2002002568A0 (en) 2002-06-30

Similar Documents

Publication Publication Date Title
EA200301324A1 (ru) Вакцина mycoplasma bovis и способы сокращения пневмонии у животных
EA200301323A1 (ru) Однократная вакцинация mycoplasma hyopneumoniae
MXPA03011924A (es) Vacuna de micoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado.
RU2010149495A (ru) Новые адъювантные композиции
BRPI0418317A (pt) vacina de aumento de crescimento à base de epitopo de neutralização
EA200500275A1 (ru) Вакцина против инфекций респираторной и репродуктивной систем крупного рогатого скота
NZ627888A (en) Materials and methods for respiratory disease control in canines
ECSP024257A (es) Proteinas antigenas del virus de la enfermedad de la mancha blanca en el camaron y usos de las mismas
DE69030383D1 (de) Impfstoff-Konjugate zur Behandlung von Vogelkrankheiten
ATE517184T1 (de) Hcv ns3/4a kodierende nukleinsäure
BR0208896A (pt) Vacina contra o vìrus da febre do nilo
AR047581A1 (es) Vacunas de calicivirus felino
JP5865839B2 (ja) 粘膜アジュバント組成物
BR0110791A (pt) Composição, métodos para induzir uma resposta imune em um indivìduo contra um imunogene, para modular o sistema imune de um indivìduo e para imunizar um indivìduo contra um patógeno, vacina recombinante, e patógeno atenuado vivo
DE69833568D1 (de) Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe
CY1116862T1 (el) Εμβολιασμος μιας δοσης me mycoplasma hyopneumoniae
Monika et al. Homologous and heterologous antibody response following foot-and-mouth disease outbreak in vaccinated cattle
El-Bagoury et al. Evaluation of inactivated Rift valley fever virus vaccine adjuvanted with montanide oil ISA 201 VG
Subramaniam et al. Immune status of commercial chicks against Newcastle disease by live-in-oil vaccines
Subha Ganguly New generation vaccines for livestock diseases.
TH75687A (th) วัคซีนไวรัสโรคโลหิตจางในไก่จากเซลล์ไลน์
LV12736A (en) Method for producing concentrated antigen composition against swine erysipelas disease
RU2002102549A (ru) Способ вакцинопрофилактики вирусных болезней телят
TH92454B (th) วัคซีนที่ใช้ทางปาก, วิธีการเตรียมของมันและการใช้วัคซีนเหล่านี้